Physician profile

Khaled M Kebaish

Orthopaedic Surgery · Baltimore, MD

NPI 1487618302

$3,048,038.19

in general payments reported to CMS, 2019-2025

17 companies · $407K in 2025

The $407K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Royalty Or License$1,042,063.22
Acquisitions$78,450.84
Consulting Fee$45,423.60
Travel and Lodging$2,921.99
Food and Beverage$987.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $1,431,288.45 2019-2025 Yukon Oct Spinal System, Capri Corpectomy Cage System
Depuy Synthes Products, INC. $794,607.26 2019-2025 Trialtis, Expedium
Orthofix Medical, INC. $336,881.91 2019-2025 Firebird Nxg, Physio-Stim
Vb Spine LLC $197,189.95 2025 Yukon Oct Spinal System
Medical Device Business Services, INC. $115,998.62 2019-2025 Expedium, Symphony
Zimmer Biomet Holdings, INC. $78,450.84 2023 Archimis
Spinecraft, LLC $66,679.14 2020-2025 Astra Spine System
Ethicon INC. $17,010.22 2020-2023 Surgiflo Hemostatic Matrix
Ethicon US, LLC $5,400.00 2021
Nuvasive, INC. $3,845.65 2021-2022
Circinus Medical Technology LLC $200.03 2025 Bolt Navigation
Medtronic, INC. $141.11 2022
Depuy Synthes Sales INC. $124.45 2022
Medtronic USA, INC. $124.44 2019
Seaspine Orthopedics Corporation $96.12 2022

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$63,616.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Khaled M Kebaish

$3,048,038.19

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $407K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/66459/khaled-m-kebaish

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.